Results 151 to 160 of about 25,524 (191)
Effect of sialidase inhibitors on a plaque community biofilm model. [PDF]
Access MicrobiolRamalingam C +4 more
europepmc +1 more source
Host nucleolin-targeting unique peptide drugs as potent broad-spectrum anti-influenza therapies. [PDF]
PNAS NexusNguyen TH +16 more
europepmc +1 more source
Management of Newborns Exposed to Maternal Influenza: A Scoping Review. [PDF]
Life (Basel)Kadaj A +6 more
europepmc +1 more source
Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on upper respiratory tract infections - rational antimicrobial use. [PDF]
Singapore Med JLim B +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1999
Oseltamivir is the oral prodrug of GS4071, a selective inhibitor of influenza A and B viral neuraminidase. After absorption from the gastrointestinal tract oseltamivir is efficiently converted to GS4071, which is maintained at high and sustained concentrations in plasma. Based on studies in rats and ferrets, GS4071 appears to be effectively distributed
A, Bardsley-Elliot, S, Noble
openaire +3 more sources
Oseltamivir is the oral prodrug of GS4071, a selective inhibitor of influenza A and B viral neuraminidase. After absorption from the gastrointestinal tract oseltamivir is efficiently converted to GS4071, which is maintained at high and sustained concentrations in plasma. Based on studies in rats and ferrets, GS4071 appears to be effectively distributed
A, Bardsley-Elliot, S, Noble
openaire +3 more sources
Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid
Journal of Clinical Pharmacology, 2008 Oseltamivir is a potent, selective, oral neuraminidase inhibitor for the treatment and prophylaxis of influenza. Plasma concentrations of the active metabolite, oseltamivir carboxylate, are increased in the presence of probenecid, suggesting that the ...
Craig R Rayner +2 more
exaly +2 more sources